Rockbridge Investment Management, Lcc Amgen Inc Transaction History

Rockbridge Investment Management, Lcc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $592,201 - $668,073	-2,316 Reduced 83.01%	474 $137 Million
Q3 2022 May 28, 2024	SELL	$224.46 - $253.15 $86,192 - $97,209	-384 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$230.71 - $256.74 $534,324 - $594,609	-2,316 Reduced 85.78%	384 $93,000
Q1 2022 May 28, 2024	BUY	$219.27 - $242.57 $592,029 - $654,939	2,700 New	2,700 $652,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $39,776 - $45,520	200 Added 7.72%	2,790 $628,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $101,889 - $119,376	480 Added 22.75%	2,590 $550,000
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $7,007 - $7,774	30 Added 1.44%	2,110 $514,000
Q1 2021 May 20, 2021	SELL	$221.91 - $258.6 $14,867 - $17,326	-67 Reduced 3.12%	2,080 $518,000
Q4 2020 Mar 04, 2021	BUY	$216.38 - $257.67 $14,497 - $17,263	67 Added 3.22%	2,147 $494,000
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $1,877 - $2,087	8 Added 0.39%	2,080 $529,000
Q2 2020 Aug 20, 2020	BUY	$197.81 - $242.74 $409,862 - $502,957	2,072 New	2,072 $489,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.